Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Robert Maganini"'
Autor:
Shelly Cummings, Erin Mundt, Ann Marie Miller, TinaMarie Bauman, Thomas Slavin, Robert Maganini
Publikováno v:
Cancer Research. 83:P5-03
BACKGROUND Accurate interpretation of hereditary cancer germline genetic variants is critical to ensuring appropriate care. Myriad Genetics has developed tools that are instrumental in the accurate classification of variants, including a previously d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a0e95e899633256545049a469102751
https://doi.org/10.1158/1538-7445.sabcs22-p5-03-03
https://doi.org/10.1158/1538-7445.sabcs22-p5-03-03
Autor:
Jennifer A. Crozier, Julie Barone, Pat Whitworth, Abraham Cheong, Robert Maganini, Jose Perez Tamayo, Patricia Dauer, Shiyu Wang, William Audeh, Annuska M. Glas
Publikováno v:
Journal of surgical oncology. 125(4)
With increased neoadjuvant therapy recommendations for early-stage breast cancer patients due to the COVID-19 pandemic, it is imperative that molecular diagnostic assays provide reliable results from preoperative core needle biopsies (CNB). The study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376f5e4de99dcb5161715e430db51127
https://pubmed.ncbi.nlm.nih.gov/34964996
https://pubmed.ncbi.nlm.nih.gov/34964996
Autor:
Andrea Menicucci, Virginia G. Kaklamani, Carlos A. Encarnacion, Karen L. Tedesco, Robert Maganini, Pat Whitworth, Josien C. Haan, Amy Truitt, Jennifer A. Crozier, Joyce O'Shaughnessy, Rakhshanda Layeequr Rahman, Yuan Yuan, Sami Diab, Julie Barone, William Audeh
Publikováno v:
Journal of Clinical Oncology. 39:563-563
563 Background: The 80-gene signature (BluePrint/BP) classifies early-stage breast cancers based on functional molecular pathways as luminal, HER2, or Basal-type. In the NBRST study, 13% of immunochemistry (IHC) defined ER+ HER2- cancers reclassified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61f5ee2505a8b349124d6dc36c528a17
https://doi.org/10.1200/jco.2021.39.15_suppl.563
https://doi.org/10.1200/jco.2021.39.15_suppl.563
Autor:
Kalyan Banda, William Audeh, Beth Lesnikoski, Charles E. Cox, Andrea Menicucci, Jennifer A. Crozier, Julie Barone, Robert Maganini, Erin Yoder, Benjamin Nota, Amy Truitt, Thomas Lomis, Sami Diab, Ian Grady
Publikováno v:
Cancer Research. 81:PS14-11
Background: Male breast cancer (MaBC) is rare, comprising Methods: This analysis included a total of 817 breast tumor samples sent to Agendia, Inc. (Irvine, CA) for MP and BP testing. Full-transcriptome microarray data were available for 1) a subset
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f44c8f9c1642885c4d1c6f5b8a8f692
https://doi.org/10.1158/1538-7445.sabcs20-ps14-11
https://doi.org/10.1158/1538-7445.sabcs20-ps14-11
Autor:
A Valencia, SJ Pain, SG Smith, MH Shere, Sheldon Feldman, BS Schwartzberg, R Whitney, HM Bu-Ali, Craig D. Shriver, Robert Maganini, M Chen-Seeto, Oma Abdelatif, S Kavia, Lyn Jones, Simon Cawthorn, JL Brehm, JM Bernard, A Juette, EB Whitacre, JM Lewin, S Govindarajulu
Publikováno v:
Cancer Research. 76:P3-13
Introduction: Percutaneous laser ablation of early stage primary breast cancer remains investigational. A multicenter, international clinical trial (NCT01478438) was completed to determine feasibility of this technique. Methods: Patients with a singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac54aa3fb9342e3f7887fc743dd5986d
https://doi.org/10.1158/1538-7445.sabcs15-p3-13-03
https://doi.org/10.1158/1538-7445.sabcs15-p3-13-03
Autor:
Hanadi Bu-Ali, Simon Cawthorn, Barbara Schwartzberg, Lyn Jones, Mike Shere, John M. Lewin, Craig D. Shriver, Simon Smith, Jacqueline Bernard, Sanjay Kavia, Eric Whitacre, Robert Maganini, Arne Juette, Sheldon Feldman, Margaret Chen-Seetoo, Osama Abdelatif, S. Govindarajulu, Alexandra Valencia, Simon Pain, Roger Whitney
An institutional review board-approved, multicenter clinical trial was designed to determine the efficacy and outcome of percutaneous laser ablation (PLA) in the treatment of invasive ductal breast carcinoma (IDC). Post-ablation magnetic resonance im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef32cc1344b2884581893401a1c4efb1
https://europepmc.org/articles/PMC6828100/
https://europepmc.org/articles/PMC6828100/
Autor:
Sherene Ishtihar, Bret Taback, Robert Gardner, Barbara S. Schwartzberg, John M. Lewin, Kambiz Dowlatshahi, Robert Maganini, Margaret Chen, William P. Mansfield, Miguel H. Del Toro
Publikováno v:
Journal of the American College of Surgeons. 227:e83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c99728965500e6c85d3332e4446fa8bc
https://doi.org/10.1016/j.jamcollsurg.2018.08.223
https://doi.org/10.1016/j.jamcollsurg.2018.08.223
Autor:
Kris Wilcox, Jaydeep R Joshi, Konstantin V. Slavin, Hui Xie, Robert Maganini, Eugene G. Lipov, Sergei Lipov, Sarah Sanders
Publikováno v:
The Lancet. Oncology. 9(6)
Debilitating hot flushes and sleep dysfunction often affect survivors of breast cancer, most notably in those taking anti-oestrogen medications. Conventional treatments have been only partially effective in diminishing these issues, and some have ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5b9d3e147a8e16e33480c9aaf4bc329
https://pubmed.ncbi.nlm.nih.gov/19482246
https://pubmed.ncbi.nlm.nih.gov/19482246